Scientists from the University of California identified psychedelic, which can accelerate the process of treating mental disorders, including depression, without causing hallucinations. Reports about it The Guardian.
According to the study, the special interest of scientists has caused a previously not studied non-valuation unit AAZ-A-154. Its properties were checked in animal studies, and it had an impact similar to the influence of classical hallucinogenic psychedelines.
“The drug is currently undergoing safety tests before getting into the early stages of the people’s tests,” said David Olson, Associate Professor of the Department of Chemistry of California University.
Psychedelic is a drug based drug, changing consciousness. Researchers seek to use the therapeutic potential of psychedelics for the treatment of depression and post-traumatic disorder. While neuroleptics usually work, changing the chemical composition of the brain, psychedelica contributes to the plasticity of neurons, essentially allowing the brain to rebuild.
The publication indicates that scientists from the London Imperial College have previously discovered the effectiveness of “magic fungi” containing psilocybin, in the treatment of medium and severe depressive disorder.
Previously nutritionists called products to combat depression. Among the improvement of the mood of products, experts called dark chocolate, fatty fish and egg yolks.